Canadian Clinics are Marketing Unproven Stem Cell Treatments

Written by Regenerative Medicine

New empirical study examines Canadian companies and clinics engaged in direct-to-consumer online marketing of purported stem cell treatments. Future Science Group today announces the publication of a new peer-reviewed study that surveys the Canadian direct-to-consumer marketplace of companies advertising putative stem cell treatments for various clinical indications. “Direct-to-Consumer Marketing of Stem Cell Interventions by Canadian Businesses” is authored by Leigh Turner, a Canadian citizen and Associate Professor at the University of Minnesota’s Center for Bioethics, School of Public Health, and College of Pharmacy (MN, USA), and published in the industry-leading journal Regenerative Medicine. In the article, Turner identifies a total...

To view the full article, please register now for access

It's completely free